Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2014 4
2015 2
2016 4
2017 3
2019 1
2021 3
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
Hughes TP, Mauro MJ, Cortes JE, Minami H, Rea D, DeAngelo DJ, Breccia M, Goh YT, Talpaz M, Hochhaus A, le Coutre P, Ottmann O, Heinrich MC, Steegmann JL, Deininger MWN, Janssen JJWM, Mahon FX, Minami Y, Yeung D, Ross DM, Tallman MS, Park JH, Druker BJ, Hynds D, Duan Y, Meille C, Hourcade-Potelleret F, Vanasse KG, Lang F, Kim DW. Hughes TP, et al. Among authors: meille c. N Engl J Med. 2019 Dec 12;381(24):2315-2326. doi: 10.1056/NEJMoa1902328. N Engl J Med. 2019. PMID: 31826340 Free PMC article. Clinical Trial.
Taxanes in paediatric oncology: and now?
André N, Meille C. André N, et al. Among authors: meille c. Cancer Treat Rev. 2006 Apr;32(2):65-73. doi: 10.1016/j.ctrv.2005.12.010. Epub 2006 Feb 23. Cancer Treat Rev. 2006. PMID: 16497442 Review.
Metronomics chemotherapy: time for computational decision support.
Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F. Barbolosi D, et al. Among authors: meille c. Cancer Chemother Pharmacol. 2014 Sep;74(3):647-52. doi: 10.1007/s00280-014-2546-1. Epub 2014 Aug 1. Cancer Chemother Pharmacol. 2014. PMID: 25082520 Review.
A framework to guide dose & regimen strategy for clinical drug development.
Sander O, Magnusson B, Ludwig I, Jullion A, Meille C, Lorand D, Bornkamp B, Hinder M, Kovacs SJ, Looby M. Sander O, et al. Among authors: meille c. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1276-1280. doi: 10.1002/psp4.12701. Epub 2021 Sep 25. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34562310 Free PMC article.
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies.
Bauer S, Demetri GD, Halilovic E, Dummer R, Meille C, Tan DSW, Guerreiro N, Jullion A, Ferretti S, Jeay S, Van Bree L, Hourcade-Potelleret F, Wuerthner JU, Fabre C, Cassier PA. Bauer S, et al. Among authors: meille c. Br J Cancer. 2021 Aug;125(5):687-698. doi: 10.1038/s41416-021-01444-4. Epub 2021 Jun 17. Br J Cancer. 2021. PMID: 34140638 Free PMC article. Clinical Trial.
Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment.
Wilbaux M, Demanse D, Gu Y, Jullion A, Myers A, Katsanou V, Meille C. Wilbaux M, et al. Among authors: meille c. CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):1122-1134. doi: 10.1002/psp4.12831. Epub 2022 Jun 21. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35728123 Free PMC article. Clinical Trial.
23 results